Buckingham Strategic Wealth, LLC Astrazeneca PLC Transaction History
Buckingham Strategic Wealth, LLC
- $8.98 Billion
- Q2 2024
A detailed history of Buckingham Strategic Wealth, LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Buckingham Strategic Wealth, LLC holds 8,987 shares of AZN stock, worth $676,002. This represents 0.01% of its overall portfolio holdings.
Number of Shares
8,987
Previous 8,026
11.97%
Holding current value
$676,002
Previous $543,000
28.91%
% of portfolio
0.01%
Previous 0.01%
Shares
18 transactions
Others Institutions Holding AZN
# of Institutions
1,343Shares Held
492MCall Options Held
4.99MPut Options Held
3.19M-
Price T Rowe Associates Inc Baltimore, MD64.9MShares$4.88 Billion0.61% of portfolio
-
Primecap Management CO Pasadena, CA42.6MShares$3.2 Billion2.44% of portfolio
-
Wellington Management Group LLP Boston, MA40.6MShares$3.05 Billion0.58% of portfolio
-
Capital International Investors Los Angeles, CA36.7MShares$2.76 Billion0.6% of portfolio
-
Franklin Resources Inc San Mateo, CA17.6MShares$1.32 Billion0.44% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $233B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...